| 2024-06-17 | Sale | APi Group Corporation APG | 10 percent owner | 39,032 0.0143% | $38.15 | $1.49M | +0.08% | |
| 2024-03-05 | Sale | APi Group Corporation APG | 10 percent owner | 3.04M 1.0979% | $34.25 | $104.07M | -0.39% | |
| 2024-01-04 | Sale | 4D Molecular Therapeutics, Inc. FDMT | 10 percent owner | 540,000 1.2278% | $19.53 | $10.55M | +28.23% | |
| 2024-01-02 | Sale | APi Group Corporation APG | 10 percent owner | 6.5M 2.6232% | $31.30 | $203.45M | +13.41% | |
| 2023-08-28 | Inhibrx, Inc. INBX | 10 percent owner | 511,627 1.13% | $19.35 | $9.9M | +73.77% | ||
| 2023-07-18 | Sale | BridgeBio Pharma, Inc. BBIO | 10 percent owner | 1.5M 1.0576% | $35.00 | $52.5M | -10.58% | |
| 2023-06-22 | Sale | Roivant Sciences Ltd. ROIV | 10 percent owner | 13M 1.8097% | $9.90 | $128.7M | +8.43% | |
| 2023-05-09 | 4D Molecular Therapeutics, Inc. FDMT | 10 percent owner | 850,000 2.3982% | $16.00 | $13.6M | +4.5% | ||
| 2021-09-17 | PROCEPT BioRobotics Corporation PRCT | 10 percent owner | 400,000 3.0225% | $35.00 | $14M | -10.97% | ||
| 2021-09-03 | Sale | FIGS, Inc. FIGS | 10 percent owner | 84,826 0.0531% | $44.92 | $3.81M | -54.58% | |
| 2021-09-02 | Sale | FIGS, Inc. FIGS | 10 percent owner | 315,174 0.2036% | $47.28 | $14.9M | -55.36% | |
| 2021-07-29 | Rallybio Corporation RLYB | 10 percent owner | 806,000 2.6995% | $13.00 | $10.48M | -22.23% | ||
| 2020-12-15 | 4D Molecular Therapeutics, Inc. FDMT | 10 percent owner | 2.2M 4.7935% | $23.00 | $50.6M | -22.23% | ||
| 2020-12-01 | Sale | Zentalis Pharmaceuticals, Inc. ZNTL | 10 percent owner | 500,000 1.7356% | $50.50 | $25.25M | +2.62% | |
| 2020-08-26 | Inhibrx, Inc. INBX | 10 percent owner | 180,219 0.6943% | $18.92 | $3.41M | +32.73% | ||
| 2020-08-25 | Inhibrx, Inc. INBX | 10 percent owner | 85,304 0.3175% | $19.36 | $1.65M | +25.01% | ||
| 2020-08-24 | Inhibrx, Inc. INBX | 10 percent owner | 46,161 0.1645% | $19.43 | $897,001 | +19.04% | ||
| 2020-04-07 | Zentalis Pharmaceuticals, Inc. ZNTL | 10 percent owner | 1.45M 3.199% | $18.00 | $26.1M | +70.78% | ||
| 2019-06-27 | BridgeBio Pharma, Inc. BBIO | 10 percent owner | 9.41M 30.5122% | $17.00 | $160M | +6.17% | ||
| 2015-02-08 | Editas Medicine, Inc. EDIT | 2.04M 8.0725% | $16.04 | $32.73M |